AFFIX Labs launches world’s first long-lasting surface treatment to kill the coronavirus

AFFIX Labs launches world’s first long-lasting surface treatment to kill the coronavirus

Leading chemical binding expert, AFFIX Labs has harnessed its global experience in disease prevention to create the first long-lasting surface treatment proven to kill COVID-19, notes a press communiqué from the Finland-based organization. Si-Quat combines a safe and well- established disinfectant and a proprietary chemical binding technique, so that the active ingredient can kill viruses, including SARS-COV-2. Testing at Portugal’s Biochemistry Institute at the University of Lisbon proves that Si-Quat effectively kills the COVID-19 pathogens that it comes into contact with.

“Tragedies have unfolded across the globe, affecting different countries at varying degrees. The second waves of COVID- 19 are just appearing on the horizon. This long-lasting surface treatment is a viable, accessible solution across cultures. By killing the COVID-19 pathogen on surfaces before it can infect people, the Si-Quat solution is a game changer. It can provide increased security and peace of mind to your communities, as well as your customers,” says Tom Sam, CEO of AFFIX Labs.

Si-Quat has been tested to kill 99.99% of microbes within minutes, while still being fully safe to touch. Proven to be effective for about a month on frequently touched surfaces, it is the longest lasting anti-viral surface treatment available to reduce the spread of the novel coronavirus. The product is non-corrosive, free from silver salts and heavy metal nanoparticles, and perfectly safe to touch.

Several major agencies around the globe have already accepted quaternary ammonium, the main ingredient in the surface coating, to be an effective surface treatment against the novel coronavirus, including the World Health Organization (WHO), the US Environmental Protection Agency, the American Chemistry Council (ACC) and the European Chemical Agency (ECHA).

More Products